Avenue Biosciences

Palo Alto, United States

Avenue Biosciences is a transatlantic biotech business that specializes on innovative protein engineering technologies.

$7.4M raised

Jan 2026

Seed

Alternative Protein Biotechnology Therapeutics

Top Investors

DimerentTesiInventureVoima VenturesBalnord

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Avenue Biosciences

How much funding has Avenue Biosciences raised?

Avenue Biosciences has raised $7.4M in total funding. The most recent round was Seed. The last funding was announced in January 2026.

Who are Avenue Biosciences's investors?

Avenue Biosciences's investors include Dimerent, Tesi, Inventure, Voima Ventures, Balnord.

Where is Avenue Biosciences headquartered?

Avenue Biosciences is headquartered in Palo Alto, United States.

What does Avenue Biosciences do?

Avenue Biosciences is a transatlantic biotech business that specializes on innovative protein engineering technologies.

What stage is Avenue Biosciences at?

Avenue Biosciences is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 12, 2026.

MLA

"Avenue Biosciences — Funding & Investors." VCBacked, January 12, 2026, https://www.vcbacked.co/company/avenue-biosciences. Accessed June 3, 2026.

APA

VCBacked. (2026). Avenue Biosciences — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/avenue-biosciences

Wikipedia (cite web)

{{cite web |title=Avenue Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/avenue-biosciences |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 12, 2026.

Similar Companies in Alternative Protein